Role of DNA methylation in the association of lung function with body mass index: a two-step epigenetic Mendelian randomisation study.
Body mass index
DNA methylation
Effect mediation
Lung function
Mendelian randomisation
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
16 Jun 2020
16 Jun 2020
Historique:
received:
15
06
2019
accepted:
09
06
2020
entrez:
18
6
2020
pubmed:
18
6
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Low lung function has been associated with increased body mass index (BMI). The aim of this study was to investigate whether the effect of BMI on lung function is mediated by DNA methylation. We used individual data from 285,495 participants in four population-based cohorts: the European Community Respiratory Health Survey, the Northern Finland Birth Cohort 1966, the Swiss Study on Air Pollution and Lung Disease in Adults, and the UK Biobank. We carried out Mendelian randomisation (MR) analyses in two steps using a two-sample approach with SNPs as instrumental variables (IVs) in each step. In step 1 MR, we estimated the causal effect of BMI on peripheral blood DNA methylation (measured at genome-wide level) using 95 BMI-associated SNPs as IVs. In step 2 MR, we estimated the causal effect of DNA methylation on FEV In step 1, we found that BMI might have a small causal effect on DNA methylation levels (less than 1% change in methylation per 1 kg/m2 increase in BMI) at two CpGs (cg09046979 and cg12580248). In step 2, we found no evidence of a causal effect of DNA methylation at cg09046979 on lung function. We could not estimate the causal effect of DNA methylation at cg12580248 on lung function as we could not find publicly available data on the association of this CpG with SNPs. To our knowledge, this is the first paper to report the use of a two-step MR approach to assess the role of DNA methylation in mediating the effect of a non-genetic factor on lung function. Our findings do not support a mediating effect of DNA methylation in the association of lung function with BMI.
Sections du résumé
BACKGROUND
BACKGROUND
Low lung function has been associated with increased body mass index (BMI). The aim of this study was to investigate whether the effect of BMI on lung function is mediated by DNA methylation.
METHODS
METHODS
We used individual data from 285,495 participants in four population-based cohorts: the European Community Respiratory Health Survey, the Northern Finland Birth Cohort 1966, the Swiss Study on Air Pollution and Lung Disease in Adults, and the UK Biobank. We carried out Mendelian randomisation (MR) analyses in two steps using a two-sample approach with SNPs as instrumental variables (IVs) in each step. In step 1 MR, we estimated the causal effect of BMI on peripheral blood DNA methylation (measured at genome-wide level) using 95 BMI-associated SNPs as IVs. In step 2 MR, we estimated the causal effect of DNA methylation on FEV
RESULTS
RESULTS
In step 1, we found that BMI might have a small causal effect on DNA methylation levels (less than 1% change in methylation per 1 kg/m2 increase in BMI) at two CpGs (cg09046979 and cg12580248). In step 2, we found no evidence of a causal effect of DNA methylation at cg09046979 on lung function. We could not estimate the causal effect of DNA methylation at cg12580248 on lung function as we could not find publicly available data on the association of this CpG with SNPs.
CONCLUSIONS
CONCLUSIONS
To our knowledge, this is the first paper to report the use of a two-step MR approach to assess the role of DNA methylation in mediating the effect of a non-genetic factor on lung function. Our findings do not support a mediating effect of DNA methylation in the association of lung function with BMI.
Identifiants
pubmed: 32546146
doi: 10.1186/s12890-020-01212-9
pii: 10.1186/s12890-020-01212-9
pmc: PMC7298775
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
171Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1002319
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S019669/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Références
Genet Epidemiol. 2016 May;40(4):304-14
pubmed: 27061298
Hum Mol Genet. 2017 Aug 1;26(15):3001-3013
pubmed: 28453778
Stat Methods Med Res. 2012 Jun;21(3):223-42
pubmed: 21216802
Nature. 2017 Jan 5;541(7635):81-86
pubmed: 28002404
Int J Epidemiol. 2015 Apr;44(2):512-25
pubmed: 26050253
Stat Med. 2008 Apr 15;27(8):1133-63
pubmed: 17886233
Allergy. 2018 Jan;73(1):153-164
pubmed: 28675761
Chest. 2016 Jun;149(6):1525-34
pubmed: 26836925
J Appl Physiol (1985). 2010 Jan;108(1):206-11
pubmed: 19875713
Int J Obes Relat Metab Disord. 1999 Sep;23(9):979-85
pubmed: 10490805
Genetics. 2010 Nov;186(3):767-73
pubmed: 21062962
Hum Mol Genet. 2017 Aug 1;26(15):3014-3027
pubmed: 28854564
Genet Epidemiol. 2013 Nov;37(7):658-65
pubmed: 24114802
Stat Med. 2017 May 20;36(11):1783-1802
pubmed: 28114746
BMC Pulm Med. 2017 Mar 20;17(1):54
pubmed: 28320365
Int J Epidemiol. 2012 Feb;41(1):161-76
pubmed: 22422451
J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):570-581.e10
pubmed: 28967546
Epigenetics Chromatin. 2009 Jun 08;2(1):7
pubmed: 19505295
Eur Respir J. 2019 Jul 4;54(1):
pubmed: 31073081
Respir Res. 2008 Apr 04;9:31
pubmed: 18394165
Int J Biostat. 2016 Nov 1;12(2):
pubmed: 27092657
Genome Biol. 2016 Mar 31;17:61
pubmed: 27036880
Epigenomics. 2017 Jul;9(7):971-984
pubmed: 28621160
Nature. 2015 Feb 12;518(7538):197-206
pubmed: 25673413